FDA Inspection 1057284 — Tandem Diabetes Care, Inc.
The FDA completed an inspection of Tandem Diabetes Care, Inc. on June 19, 2018 in San Diego, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 19, 2018
- Fiscal Year
- 2018
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- San Diego, CA (United States)
Additional Details
Sponsor, Contract Research Organization